Tandem Diabetes Care, Inc.
Simbolis: TNDM
NASDAQ
35.24
USDRinkos kaina šiandien
-10.3481
P/E santykis
-0.1231
PEG koeficientas
2.28B
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Tandem Diabetes Care, Inc. (TNDM) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1992.9 | 467.9 | 616.9 | 623.8 | |||||||||||||
balance-sheet.row.short-term-investments | 1595.91 | 409 | 444.4 | 552.6 | |||||||||||||
balance-sheet.row.net-receivables | 395.98 | 105.6 | 114.7 | 110.7 | |||||||||||||
balance-sheet.row.inventory | 580.59 | 157.9 | 111.1 | 68.6 | |||||||||||||
balance-sheet.row.other-current-assets | 58.89 | 16.6 | 7.2 | 8.4 | |||||||||||||
balance-sheet.row.total-current-assets | 3028.36 | 748 | 850 | 811.5 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 673.65 | 164.3 | 179.2 | 77.9 | |||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.intangible-assets | 2.78 | 2.8 | 4.6 | 6.6 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2.78 | 2.8 | 4.6 | 6.6 | |||||||||||||
balance-sheet.row.long-term-investments | 20.2 | 10.1 | 8.3 | 0 | |||||||||||||
balance-sheet.row.tax-assets | -10.1 | -10.1 | -8.3 | 0 | |||||||||||||
balance-sheet.row.other-non-current-assets | 78.5 | 37.6 | 19 | 9.1 | |||||||||||||
balance-sheet.row.total-non-current-assets | 765.03 | 204.7 | 202.8 | 93.6 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 3793.39 | 952.7 | 1052.8 | 905.1 | |||||||||||||
balance-sheet.row.account-payables | 208.04 | 49.6 | 55.7 | 28 | |||||||||||||
balance-sheet.row.short-term-debt | 68.28 | 17.1 | 13.1 | 9.3 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.long-term-debt-total | 1606.27 | 398.6 | 406.8 | 305.4 | |||||||||||||
Deferred Revenue Non Current | 58.61 | 13.3 | 16.9 | 16.9 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 332.09 | 84.6 | 77.6 | 84.4 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 1769.59 | 443.8 | 447.5 | 340.2 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 537.13 | 130.6 | 136.6 | 33.2 | |||||||||||||
balance-sheet.row.total-liab | 2497.77 | 639 | 612.8 | 472 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.common-stock | 0.26 | 0.1 | 0.1 | 0.1 | |||||||||||||
balance-sheet.row.retained-earnings | -3615.5 | -951.8 | -729.2 | -634.6 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -2.12 | 1.4 | -1.8 | -0.6 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4912.98 | 1264 | 1170.9 | 1068.3 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 1295.62 | 313.6 | 439.9 | 433.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3793.39 | 952.7 | 1052.8 | 905.1 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-equity | 1295.62 | 313.6 | 439.9 | 433.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3793.39 | - | - | - | |||||||||||||
Total Investments | 1595.91 | 409 | 444.4 | 552.6 | |||||||||||||
balance-sheet.row.total-debt | 1674.56 | 415.7 | 419.9 | 314.7 | |||||||||||||
balance-sheet.row.net-debt | 1277.57 | 356.8 | 247.4 | 243.5 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -222.61 | -222.6 | -94.6 | 15.6 | |||||||||||||
cash-flows.row.depreciation-and-amortization | 15.71 | 15.7 | 14.3 | 13.8 | |||||||||||||
cash-flows.row.deferred-income-tax | 0 | 9.1 | 0 | 4.6 | |||||||||||||
cash-flows.row.stock-based-compensation | 88.08 | 88.1 | 84.9 | 60.8 | |||||||||||||
cash-flows.row.change-in-working-capital | -17.68 | -17.7 | -4.6 | 14.4 | |||||||||||||
cash-flows.row.account-receivables | 4.28 | 4.3 | -7.8 | -31 | |||||||||||||
cash-flows.row.inventory | -46.05 | -46.1 | -42.5 | -5 | |||||||||||||
cash-flows.row.account-payables | -4.86 | -4.9 | 24.5 | 10.3 | |||||||||||||
cash-flows.row.other-working-capital | 28.95 | 29 | 21.1 | 40 | |||||||||||||
cash-flows.row.other-non-cash-items | 104.69 | 95.6 | 50.5 | 2.3 | |||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -31.81 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -51.6 | -51.6 | -43 | -23.5 | |||||||||||||
cash-flows.row.acquisitions-net | -69.5 | -69.5 | -25.7 | 9.3 | |||||||||||||
cash-flows.row.purchases-of-investments | -510.86 | -510.9 | -467.7 | -733.4 | |||||||||||||
cash-flows.row.sales-maturities-of-investments | 546.22 | 546.2 | 569.5 | 570 | |||||||||||||
cash-flows.row.other-investing-activites | 65.07 | 0 | 0 | -9.3 | |||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -85.74 | -85.7 | 33.2 | -186.9 | |||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.common-stock-issued | 6.29 | 4.2 | 17.5 | 51.3 | |||||||||||||
cash-flows.row.common-stock-repurchased | -0.54 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.other-financing-activites | 2.31 | -0.1 | -0.6 | 0.6 | |||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 4.11 | 4.1 | 16.9 | 51.9 | |||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.21 | -0.2 | 0.8 | 0.2 | |||||||||||||
cash-flows.row.net-change-in-cash | -113.65 | -113.6 | 101.3 | -23.4 | |||||||||||||
cash-flows.row.cash-at-end-of-period | 396.99 | 58.9 | 172.5 | 71.2 | |||||||||||||
cash-flows.row.cash-at-beginning-of-period | 510.64 | 172.5 | 71.2 | 94.6 | |||||||||||||
cash-flows.row.operating-cash-flow | -31.81 | -31.8 | 50.5 | 111.4 | |||||||||||||
cash-flows.row.capital-expenditure | -51.6 | -51.6 | -43 | -23.5 | |||||||||||||
cash-flows.row.free-cash-flow | -83.41 | -83.4 | 7.5 | 87.8 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 747.72 | 747.7 | 801.2 | 702.8 | |||||||||||||
income-statement-row.row.cost-of-revenue | 380.03 | 380 | 388.2 | 326.6 | |||||||||||||
income-statement-row.row.gross-profit | 367.69 | 367.7 | 413 | 376.2 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 169.67 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 83.8 | 78.8 | 0 | 0 | |||||||||||||
income-statement-row.row.operating-expenses | 522.17 | 522.2 | 474.8 | 353.6 | |||||||||||||
income-statement-row.row.cost-and-expenses | 902.2 | 902.2 | 863 | 680.1 | |||||||||||||
income-statement-row.row.interest-income | 22.86 | 22.9 | 6.1 | 0.7 | |||||||||||||
income-statement-row.row.interest-expense | -3.67 | 7.6 | 4.3 | 4.3 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 12.98 | -78.8 | -31 | 7.1 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 83.8 | 78.8 | 0 | 0 | |||||||||||||
income-statement-row.row.total-operating-expenses | 12.98 | -78.8 | -31 | 7.1 | |||||||||||||
income-statement-row.row.interest-expense | -3.67 | 7.6 | 4.3 | 4.3 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 88.47 | 15.7 | 31 | 13.8 | |||||||||||||
income-statement-row.row.ebitda-caps | -56.7 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | -151.88 | -233.2 | -61.8 | 8.8 | |||||||||||||
income-statement-row.row.income-before-tax | -220.25 | -220.3 | -92.9 | 15.9 | |||||||||||||
income-statement-row.row.income-tax-expense | 2.36 | 2.4 | 1.7 | 0.3 | |||||||||||||
income-statement-row.row.net-income | -222.61 | -222.6 | -94.6 | 15.6 |
Dažnai užduodami klausimai
Kas yra Tandem Diabetes Care, Inc. (TNDM) bendras turtas?
Tandem Diabetes Care, Inc. (TNDM) bendras turtas yra 952658000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 382418000.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.492.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra -1.276.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra -0.298.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra -0.203.
Kas yra Tandem Diabetes Care, Inc. (TNDM) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra -222611000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 415667000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 522170000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 58868000.000.